PETNet inks deal with GlaxoSmithKline

PETNet Solutions of Knoxville, TN, has signed an agreement with GlaxoSmithKline in which PETNet provides PET facilities and services to the pharmaceutical giant.

As part of the deal, PETNet will supply PET isotopes to a GlaxoSmithKline pre-clinical research site located in Mt. Vernon, U.K. Additionally, the firm will have the option, at GlaxoSmithKline’s sole discretion, to license diagnostic PET probes that are developed by GlaxoSmithKline, according to PETNet, a subsidiary of PET developer CTI Molecular Imaging.

By staff writers
March 2, 2004

Related Reading

PETNet renews Merck agreement, February 12, 2004

CTI continues growth in Q1, February 3, 2004

PETNet Solutions partners with Yerkes, January 28, 2004

PETNet signs deal with Johns Hopkins, January 27, 2004

CTI unveils Reveal Hi REZ for PET/CT, November 30, 2003

Copyright © 2004

Page 1 of 594
Next Page